Can Osteoprotegerin be a Target of Therapy in Type 2 Diabetes Mellitus?

Alexander E Berezin
  • Journal of Postgenomics Drug & Biomarker Development, January 2016, OMICS Publishing Group
  • DOI: 10.4172/2153-0769.1000172
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Professor Alexander E Berezin